Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-19 4:02 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
13,047 | $1.504 | $19,623 | 1,571,962 (Direct) |
View |
| 2024-12-17 Sale |
2024-12-18 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
12,447 | $2.466 | $30,694 | 739,819 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-18 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
14,550 | $1.796 | $26,132 | 752,266 (Direct) |
View |
| 2023-05-09 Purchase |
2023-05-10 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
20,000 | $1.2596 | $25,192 | 312,816 (Direct) |
View |
| 2023-03-17 Sale |
2023-03-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
6,999 | $1.783 | $12,479 | 292,816 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-08 4:21 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
5,441 | $5.056 | $27,510 | 194,815 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-20 4:08 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
3,394 | $6.938 | $23,548 | 198,257 (Direct) |
View |
| 2022-08-05 Purchase |
2022-08-08 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
8,606 | $5.8041 | $49,950 | 198,771 (Direct) |
View |
| 2022-06-17 Sale |
2022-06-21 4:07 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
4,552 | $4.991 | $22,719 | 190,165 (Direct) |
View |
| 2022-03-17 Sale |
2022-03-18 4:29 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
571 | $4.58 | $2,615 | 194,717 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-02 4:30 pm |
PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer |
5,563 | $18 | $100,134 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Option Award |
2025-03-17 5:17 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
1,593,000 | $0 | 2,338,009 (Direct) |
View |
| 2024-03-14 Option Award |
2024-03-15 4:30 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
1,096,000 | $0 | 1,408,816 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 09:21 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
550,000 | $0 | 744,815 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 4:48 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
91,000 | $0 | 91,000 (Direct) |
View |
| 2022-03-14 Option Award |
2022-03-16 5:08 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
116,000 | $0 | 687,288 (Direct) |
View |
| 2021-10-29 Option Award |
2021-11-01 4:48 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
26,700 | $0 | 114,550 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 5:06 pm |
N/A 2031-05-17 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
140,000 | $0 | 170,000 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 5:00 pm |
N/A 2031-01-28 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. Chief Operating Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-07-02 4:30 pm |
N/A N/A |
PORTOLA PHARMACEUTICALS INC | PTLA | Koenig Sheldon L. EVP, Chief Commercial Officer |
488 | $8.36 | 0 (Direct) |
View |